Miyashita Akiko Moni
SEC CIK 1607742 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | Dir | 24.9K | — | — | 4 | 2022-05-05 | 2025-05-01 |
Most active insiders at HALO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Torley Helen | Pres AND CEO, Dir | — | $39.85M |
| 2 | Caudill Cortney | SVP, COO | — | $2.23M |
| 3 | Posard Matthew L. | Dir | — | $2.05M |
| 4 | Connaughton Bernadette | Dir | — | $989.9K |
| 5 | Krishnan Mahesh | Dir | — | $547.8K |
| 6 | LaBrosse Nicole | SVP, CFO | — | — |
| 7 | Snyder Mark Howard | SVP, CLO | — | — |
| 8 | Appelhans Dannielle | Dir | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | DUNCAN BARBARA GAYLE | Dir | — | — |
Miyashita Akiko Moni made no open-market trades at HALO in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-02 | 2025-05-01 | HALO | HALOZYME THERAPEUTICS, INC. | Miyashita Akiko Moni | Dir | A - Grant | $0.00 | +4,165 | 24.9K | +20% | $0 |
| D | 2024-04-29 | 2024-04-25 | HALO | HALOZYME THERAPEUTICS, INC. | Miyashita Akiko Moni | Dir | A - Grant | $0.00 | +6,501 | 20.8K | +46% | $0 |
| D | 2023-05-09 | 2023-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Miyashita Akiko Moni | Dir | A - Grant | $0.00 | +8,065 | 14.3K | +130% | $0 |
| 2022-05-06 | 2022-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Miyashita Akiko Moni | Dir | A - Grant | $0.00 | +6,206 | 6,206 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations